Drug-Drug Interactions in the Management of Patients With Pulmonary Arterial Hypertension

The management of pulmonary arterial hypertension (PAH) has become more complex in recent years because of increased pharmacotherapy options and longer patient survival with increasing numbers of comorbidities. As such, more opportunities exist for drug-drug interactions between PAH-targeted medicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Sheryl, Hoang, Heather B., Yang, Jenny Z., Papamatheakis, Demosthenes G., Poch, David S., Alotaibi, Mona, Lombardi, Sandra, Rodriguez, Cynthia, Kim, Nick H., Fernandes, Timothy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Chest Physicians 2022
Materias:
Pulmonary Vascular: CHEST Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773230/
https://www.ncbi.nlm.nih.gov/pubmed/35841932
http://dx.doi.org/10.1016/j.chest.2022.06.042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773230/
https://www.ncbi.nlm.nih.gov/pubmed/35841932
http://dx.doi.org/10.1016/j.chest.2022.06.042

Ejemplares similares